Genscript Biotech Corp. | Cash Flow
Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
58,399.80
60,765.70
178,123.10
252,349.70
300,187.10
177,912.30
Depreciation, Depletion & Amortization
35,952.00
38,005.70
37,576.70
40,512.30
53,123.60
99,568.20
Other Funds
256.00
63,371.30
63,400.50
-
13,551.70
11,348.80
Funds from Operations
89,116.10
92,784.80
228,259.00
261,641.40
337,756.30
288,829.20
Changes in Working Capital
1,047.10
201.60
77,138.10
3,423.20
169,758.70
2,122,462.10
Net Operating Cash Flow
90,163.20
92,583.20
151,120.90
258,218.10
167,997.50
2,411,291.30
Capital Expenditures
66,040.10
89,403.70
57,663.60
69,714.60
232,210.30
Sale of Fixed Assets & Businesses
-
23.30
-
-
1,044.20
Purchase/Sale of Investments
26,791.40
15,144.90
21,110.30
-
38,005.60
Net Investing Cash Flow
84,656.00
70,676.20
31,777.80
64,544.80
284,056.00
Cash Dividends Paid - Total
-
-
-
-
20,534.10
Issuance/Reduction of Debt, Net
18,266.90
58,237.70
-
9,602.20
1,480.60
Net Financing Cash Flow
18,522.90
5,133.60
505,219.70
65,957.60
14,408.90
Net Change in Cash
29,452.00
24,659.90
604,235.60
254,173.90
98,244.00
Free Cash Flow
24,867.80
35,547.50
99,093.40
191,825.80
59,669.60
Net Assets from Acquisitions
-
-
-
551.10
2,906.70
Other Sources
8,175.50
3,559.40
4,775.60
4,618.70
4,956.20
Change in Capital Stock
-
-
568,620.20
75,559.80
22,871.90
Exchange Rate Effect
5,421.90
2,380.70
20,327.20
5,457.00
3,405.50
Other Uses
-
-
-
-
16,933.80
About Genscript Biotech
View Profile
